NEW YORK (GenomeWeb) – Agendia said today that Belgium's University Hospitals Leuven has agreed to participate in a co-validation effort for an in vitro diagnostic kit version of the company's MammaPrint and BluePrint breast cancer assays.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type.
This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.
This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.